This comprehensive report provides a detailed analysis of the global medical grade bioactive glass market, forecasting its trajectory through 2032. The study examines key segments including product types like 45S5 and S53P4, alongside applications in bone and dental materials. By evaluating regional trends across the Americas, APAC, and Europe, the research highlights emerging opportunities and competitive dynamics among major players such as Zimmer Biomet and Stryker. Furthermore, it explores market drivers, technological advancements, and strategic industry developments.

Executive Overview

Global Market Outlook

The global Medical Grade Bioactive Glass market is projected to experience significant growth from 2025 through 2032, maintaining a steady compound annual growth rate throughout the forecast period.

Regional Market Projections

• United States: The market for Medical Grade Bioactive Glass in the United States is estimated to increase from 2025 through 2032, growing at a consistent compound annual growth rate.
• China: The Chinese market for Medical Grade Bioactive Glass is expected to see an increase in value from 2025 to 2032, following a positive growth trajectory.
• Europe: The European market for Medical Grade Bioactive Glass is projected to expand from 2025 to 2032, characterized by a sustained compound annual growth rate.

About the Report

Produced by LP Information, Inc. (LPI), the “Medical Grade Bioactive Glass Industry Forecast” reviews total global sales for 2025 and provides a comprehensive analysis of projected sales from 2026 through 2032. The report offers a detailed analysis in US$ millions, breaking down the industry by region, market sector, and sub-sector.

Scope and Analysis

This Insight Report provides a comprehensive analysis of the global Medical Grade Bioactive Glass landscape, highlighting key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

Furthermore, the report analyzes the strategies of leading global companies, focusing on their Medical Grade Bioactive Glass portfolios and capabilities, market entry strategies, market positions, and geographic footprints to understand their unique positions in an accelerating global market.

Methodology

The report evaluates key market trends, drivers, and affecting factors shaping the global outlook. It breaks down the forecast by type, application, geography, and market size to highlight emerging pockets of opportunity. The study utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to offer a nuanced view of the current state and future trajectory of the industry.

Market Segmentation

By Type

• 45S5
• S53P4
• Others

By Application

• Bone Materials
• Dental Materials

By Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

Market Share

In terms of revenue, the global two largest companies occupied a significant portion of the market share in 2025.

Key Players

The following companies have been profiled based on primary expert input and analysis of their coverage, product portfolios, and market penetration:

• Zimmer Biomet Holdings, Inc.
• Stryker
• SCHOTT
• BonAlive Biomaterials
• NovaBone
• Beijing Xinfuyisheng High Technology
• Prosidyan
• Ferro
• Mo-Sci Corporation
• Synergy Biomedical
• 3M
• Matexcel
• Noraker
• Ugulin
• Kunshan Overseas Chinese Technology New Materials
• Zhangjiagang Lanzhi Biotechnology
• Guangzhou Kejin Material Technology

Key Questions Addressed

• What is the 10-year outlook for the global Medical Grade Bioactive Glass market?
• What factors are driving Medical Grade Bioactive Glass market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Medical Grade Bioactive Glass market opportunities vary by end market size?
• How does Medical Grade Bioactive Glass break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Medical Grade Bioactive Glass Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Medical Grade Bioactive Glass by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Medical Grade Bioactive Glass by Country/Region, 2021, 2025 & 2032

  • 2.2 Medical Grade Bioactive Glass Segment by Type

    • 2.2.1 45S5

    • 2.2.2 S53P4

    • 2.2.3 Others

    • 2.2.4 Medical Grade Bioactive Glass Sales by Type

      • 2.2.4.1 Global Medical Grade Bioactive Glass Sales Market Share by Type (2021-2026)
      • 2.2.4.2 Global Medical Grade Bioactive Glass Revenue and Market Share by Type (2021-2026)
      • 2.2.4.3 Global Medical Grade Bioactive Glass Sale Price by Type (2021-2026)

  • 2.3 Medical Grade Bioactive Glass Segment by Application

    • 2.3.1 Bone Materials

    • 2.3.2 Dental Materials

    • 2.3.3 Medical Grade Bioactive Glass Sales by Application

      • 2.3.3.1 Global Medical Grade Bioactive Glass Sale Market Share by Application (2021-2026)
      • 2.3.3.2 Global Medical Grade Bioactive Glass Revenue and Market Share by Application (2021-2026)
      • 2.3.3.3 Global Medical Grade Bioactive Glass Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Medical Grade Bioactive Glass Breakdown Data by Company

    • 3.1.1 Global Medical Grade Bioactive Glass Annual Sales by Company (2021-2026)

    • 3.1.2 Global Medical Grade Bioactive Glass Sales Market Share by Company (2021-2026)

  • 3.2 Global Medical Grade Bioactive Glass Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Medical Grade Bioactive Glass Revenue by Company (2021-2026)

    • 3.2.2 Global Medical Grade Bioactive Glass Revenue Market Share by Company (2021-2026)

  • 3.3 Global Medical Grade Bioactive Glass Sale Price by Company

  • 3.4 Key Manufacturers Medical Grade Bioactive Glass Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Medical Grade Bioactive Glass Product Location Distribution

    • 3.4.2 Players Medical Grade Bioactive Glass Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Medical Grade Bioactive Glass by Geographic Region

  • 4.1 World Historic Medical Grade Bioactive Glass Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Medical Grade Bioactive Glass Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Medical Grade Bioactive Glass Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Medical Grade Bioactive Glass Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Medical Grade Bioactive Glass Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Medical Grade Bioactive Glass Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Medical Grade Bioactive Glass Sales Growth

  • 4.4 APAC Medical Grade Bioactive Glass Sales Growth

  • 4.5 Europe Medical Grade Bioactive Glass Sales Growth

  • 4.6 Middle East & Africa Medical Grade Bioactive Glass Sales Growth

• 5 Americas

  • 5.1 Americas Medical Grade Bioactive Glass Sales by Country

    • 5.1.1 Americas Medical Grade Bioactive Glass Sales by Country (2021-2026)

    • 5.1.2 Americas Medical Grade Bioactive Glass Revenue by Country (2021-2026)

  • 5.2 Americas Medical Grade Bioactive Glass Sales by Type (2021-2026)

  • 5.3 Americas Medical Grade Bioactive Glass Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Medical Grade Bioactive Glass Sales by Region

    • 6.1.1 APAC Medical Grade Bioactive Glass Sales by Region (2021-2026)

    • 6.1.2 APAC Medical Grade Bioactive Glass Revenue by Region (2021-2026)

  • 6.2 APAC Medical Grade Bioactive Glass Sales by Type (2021-2026)

  • 6.3 APAC Medical Grade Bioactive Glass Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Medical Grade Bioactive Glass by Country

    • 7.1.1 Europe Medical Grade Bioactive Glass Sales by Country (2021-2026)

    • 7.1.2 Europe Medical Grade Bioactive Glass Revenue by Country (2021-2026)

  • 7.2 Europe Medical Grade Bioactive Glass Sales by Type (2021-2026)

  • 7.3 Europe Medical Grade Bioactive Glass Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Medical Grade Bioactive Glass by Country

    • 8.1.1 Middle East & Africa Medical Grade Bioactive Glass Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Medical Grade Bioactive Glass Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Medical Grade Bioactive Glass Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Medical Grade Bioactive Glass Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Medical Grade Bioactive Glass

  • 10.3 Manufacturing Process Analysis of Medical Grade Bioactive Glass

  • 10.4 Industry Chain Structure of Medical Grade Bioactive Glass

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Medical Grade Bioactive Glass Distributors

  • 11.3 Medical Grade Bioactive Glass Customer

• 12 World Forecast Review for Medical Grade Bioactive Glass by Geographic Region

  • 12.1 Global Medical Grade Bioactive Glass Market Size Forecast by Region

    • 12.1.1 Global Medical Grade Bioactive Glass Forecast by Region (2027-2032)

    • 12.1.2 Global Medical Grade Bioactive Glass Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Medical Grade Bioactive Glass Forecast by Type (2027-2032)

  • 12.7 Global Medical Grade Bioactive Glass Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Zimmer Biomet Holdings, Inc.

    • 13.1.1 Zimmer Biomet Holdings, Inc. Company Information

    • 13.1.2 Zimmer Biomet Holdings, Inc. Medical Grade Bioactive Glass Product Portfolios and Specifications

    • 13.1.3 Zimmer Biomet Holdings, Inc. Medical Grade Bioactive Glass Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Zimmer Biomet Holdings, Inc. Main Business Overview

    • 13.1.5 Zimmer Biomet Holdings, Inc. Latest Developments

  • 13.2 Stryker

    • 13.2.1 Stryker Company Information

    • 13.2.2 Stryker Medical Grade Bioactive Glass Product Portfolios and Specifications

    • 13.2.3 Stryker Medical Grade Bioactive Glass Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Stryker Main Business Overview

    • 13.2.5 Stryker Latest Developments

  • 13.3 SCHOTT

    • 13.3.1 SCHOTT Company Information

    • 13.3.2 SCHOTT Medical Grade Bioactive Glass Product Portfolios and Specifications

    • 13.3.3 SCHOTT Medical Grade Bioactive Glass Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 SCHOTT Main Business Overview

    • 13.3.5 SCHOTT Latest Developments

  • 13.4 BonAlive Biomaterials

    • 13.4.1 BonAlive Biomaterials Company Information

    • 13.4.2 BonAlive Biomaterials Medical Grade Bioactive Glass Product Portfolios and Specifications

    • 13.4.3 BonAlive Biomaterials Medical Grade Bioactive Glass Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 BonAlive Biomaterials Main Business Overview

    • 13.4.5 BonAlive Biomaterials Latest Developments

  • 13.5 NovaBone

    • 13.5.1 NovaBone Company Information

    • 13.5.2 NovaBone Medical Grade Bioactive Glass Product Portfolios and Specifications

    • 13.5.3 NovaBone Medical Grade Bioactive Glass Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 NovaBone Main Business Overview

    • 13.5.5 NovaBone Latest Developments

  • 13.6 Beijing Xinfuyisheng High Technology

    • 13.6.1 Beijing Xinfuyisheng High Technology Company Information

    • 13.6.2 Beijing Xinfuyisheng High Technology Medical Grade Bioactive Glass Product Portfolios and Specifications

    • 13.6.3 Beijing Xinfuyisheng High Technology Medical Grade Bioactive Glass Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Beijing Xinfuyisheng High Technology Main Business Overview

    • 13.6.5 Beijing Xinfuyisheng High Technology Latest Developments

  • 13.7 Prosidyan

    • 13.7.1 Prosidyan Company Information

    • 13.7.2 Prosidyan Medical Grade Bioactive Glass Product Portfolios and Specifications

    • 13.7.3 Prosidyan Medical Grade Bioactive Glass Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Prosidyan Main Business Overview

    • 13.7.5 Prosidyan Latest Developments

  • 13.8 Ferro

    • 13.8.1 Ferro Company Information

    • 13.8.2 Ferro Medical Grade Bioactive Glass Product Portfolios and Specifications

    • 13.8.3 Ferro Medical Grade Bioactive Glass Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 Ferro Main Business Overview

    • 13.8.5 Ferro Latest Developments

  • 13.9 Mo-Sci Corporation

    • 13.9.1 Mo-Sci Corporation Company Information

    • 13.9.2 Mo-Sci Corporation Medical Grade Bioactive Glass Product Portfolios and Specifications

    • 13.9.3 Mo-Sci Corporation Medical Grade Bioactive Glass Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Mo-Sci Corporation Main Business Overview

    • 13.9.5 Mo-Sci Corporation Latest Developments

  • 13.10 Synergy Biomedical

    • 13.10.1 Synergy Biomedical Company Information

    • 13.10.2 Synergy Biomedical Medical Grade Bioactive Glass Product Portfolios and Specifications

    • 13.10.3 Synergy Biomedical Medical Grade Bioactive Glass Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.10.4 Synergy Biomedical Main Business Overview

    • 13.10.5 Synergy Biomedical Latest Developments

  • 13.11 3M

    • 13.11.1 3M Company Information

    • 13.11.2 3M Medical Grade Bioactive Glass Product Portfolios and Specifications

    • 13.11.3 3M Medical Grade Bioactive Glass Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.11.4 3M Main Business Overview

    • 13.11.5 3M Latest Developments

  • 13.12 Matexcel

    • 13.12.1 Matexcel Company Information

    • 13.12.2 Matexcel Medical Grade Bioactive Glass Product Portfolios and Specifications

    • 13.12.3 Matexcel Medical Grade Bioactive Glass Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.12.4 Matexcel Main Business Overview

    • 13.12.5 Matexcel Latest Developments

  • 13.13 Noraker

    • 13.13.1 Noraker Company Information

    • 13.13.2 Noraker Medical Grade Bioactive Glass Product Portfolios and Specifications

    • 13.13.3 Noraker Medical Grade Bioactive Glass Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.13.4 Noraker Main Business Overview

    • 13.13.5 Noraker Latest Developments

  • 13.14 Ugulin

    • 13.14.1 Ugulin Company Information

    • 13.14.2 Ugulin Medical Grade Bioactive Glass Product Portfolios and Specifications

    • 13.14.3 Ugulin Medical Grade Bioactive Glass Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.14.4 Ugulin Main Business Overview

    • 13.14.5 Ugulin Latest Developments

  • 13.15 Kunshan Overseas Chinese Technology New Materials

    • 13.15.1 Kunshan Overseas Chinese Technology New Materials Company Information

    • 13.15.2 Kunshan Overseas Chinese Technology New Materials Medical Grade Bioactive Glass Product Portfolios and Specifications

    • 13.15.3 Kunshan Overseas Chinese Technology New Materials Medical Grade Bioactive Glass Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.15.4 Kunshan Overseas Chinese Technology New Materials Main Business Overview

    • 13.15.5 Kunshan Overseas Chinese Technology New Materials Latest Developments

  • 13.16 Zhangjiagang Lanzhi Biotechnology

    • 13.16.1 Zhangjiagang Lanzhi Biotechnology Company Information

    • 13.16.2 Zhangjiagang Lanzhi Biotechnology Medical Grade Bioactive Glass Product Portfolios and Specifications

    • 13.16.3 Zhangjiagang Lanzhi Biotechnology Medical Grade Bioactive Glass Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.16.4 Zhangjiagang Lanzhi Biotechnology Main Business Overview

    • 13.16.5 Zhangjiagang Lanzhi Biotechnology Latest Developments

  • 13.17 Guangzhou Kejin Material Technology

    • 13.17.1 Guangzhou Kejin Material Technology Company Information

    • 13.17.2 Guangzhou Kejin Material Technology Medical Grade Bioactive Glass Product Portfolios and Specifications

    • 13.17.3 Guangzhou Kejin Material Technology Medical Grade Bioactive Glass Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.17.4 Guangzhou Kejin Material Technology Main Business Overview

    • 13.17.5 Guangzhou Kejin Material Technology Latest Developments

• 14 Research Findings and Conclusion